Impact of Ribavirin Formulation and Host Risk Factors on 90-Day Mortality in Hematopoietic Cell Transplant (HCT) Patients With RSV Infection
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.12.451
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2018
Authors
Publisher
Elsevier BV